The ROE (Return on Equity) of Heidelberg Pharma AG (HPHA.DE) is -62.79%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-11-30 | -62.79% |
| 2023-11-30 | -41.24% |
| 2022-11-30 | -29.56% |
| 2021-11-30 | -390.20% |
| 2020-11-30 | -142.63% |
| 2019-11-30 | -62.28% |
| 2018-11-30 | -45.09% |
| 2017-11-30 | -29.63% |
| 2016-11-30 | -65.49% |
| 2015-11-30 | -69.11% |